In this episode, AJEM is broadcasting from Berlin's MIND Foundation INSIGHT ‘23 meeting with Matt Johnson, PhD, a Professor of Psychiatry and Behavioral Science at Johns Hopkins University School of Medicine in Baltimore. At the meeting, Dr. Johnson gave a presentation entitled, "Preparing of Approved Psychedelic Medicine: Dangerous Trajectories in Psychedelic Science."

Visit us at endocannabinoidmedicine.com

Visit us at endocannabinoidmedicine.com

In this episode, AJEM shines a light on Staci Gruber, PhD, Director of the Cognitive and Clinical Neuroimaging Core and Director of the Marijuana Investigations for Neuroscientific Discovery (MIND) program 
at McLean Hospital, in Belmont, Massachusetts, and an Associate Professor of Psychiatry at Harvard Medical School in Cambridge.

Visit us at endocannabinoidmedicine.com

Visit us at endocannabinoidmedicine.com

In this episode, AJEM talks with Professor Yossi Tam, DMD, PhD, MSc, BMedSc, Director Israel's Multidisciplinary Center for Cannabinoid Research, about his lengthy career in cannabis research. 

Visit us at endocannabinoidmedicine.com

Visit us at endocannabinoidmedicine.com

In this episode, AJEM talks with Australia's former Deputy Health Minister Professor John Skerritt, PhD, about the lessons learned from medical cannabis as Australia becomes the first nation to legalize psilocybin and MDMA to treat depression and PTSD.

Visit us at endocannabinoidmedicine.com

Visit us at endocannabinoidmedicine.com

In this episode, AJEM talks with Integrative Medicine Physician Dustin Sulak, DO, about the merits of low- and ultra-low doses of cannabinoid-based therapy.

Visit us at endocannabinoidmedicine.com

Visit us at endocannabinoidmedicine.com

In this episode, AJEM talks with Israeli Pediatric Neurologist Adi Aran, MD, about his latest study on cannabinoid-based therapy for children with autism spectrum disorder.

Visit us at endocannabinoidmedicine.com

Visit us at endocannabinoidmedicine.com

In this episode, AJEM's Editor in Chief, Senior Managing Editor and Brand Director talk about challenges and opportunities for the journal and what led them to AJEM in the first place.

Visit us at endocannabinoidmedicine.com

Visit us at endocannabinoidmedicine.com

In this episode, clinical cannabis pharmacist Stacia Woodcock, PharmD, talks with AJEM's Editor-in-Chief Leslie Apgar, MD, about dosing, administration, and polypharmacy. Dr. Woodcock is currently working as a Pharmacy Editor for GoodRx Health. She delights in using her clinical expertise to help educate practitioners, patients, and communities in an effort to remove the pervasive stigma surrounding cannabis as medicine.

Visit us at endocannabinoidmedicine.com

Visit us at endocannabinoidmedicine.com

In this episode, we talk with Harvard-trained Peter Grinspoon, MD, about the potential for cannabinoids to treat substance use disorder in physicians. Be sure to listen to the end, where Dr. Grinspoon recounts a personal story with legendary astronomer and 'Cosmos' author Carl Sagan.

Visit us at endocannabinoidmedicine.com

Visit us at endocannabinoidmedicine.com

In this episode, clinical cannabis pharmacist Leah Johnson, PharmD, urges nationwide adoption of California's "Ryan's Law", which allows terminally ill patients to use medical cannabis in a hospital or other qualified medical care facility.

Visit us at endocannabinoidmedicine.com

Visit us at endocannabinoidmedicine.com